The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global neuromorphic chip market was valued at US$ 2.1 Billion in 2021.
We expect the global neuromorphic chip market to exhibit a CAGR of 20.7% during 2022-2027.
The extensive application of neuromorphic chips in robotics and neuroscience research activities, to
mimic the functions of the nervous system and human brain, is primarily driving the global
neuromorphic chip market.
The sudden outbreak of the COVID-19 pandemic has led to the widespread adoption of neuromorphic
chip-based computing systems to produce antibodies in quick and accurate manner against the
Based on the offering, the global neuromorphic chip market has been segmented into hardware and
software. Currently, hardware holds the majority of the total market share.
Based on the end use industry, the global neuromorphic chip market can be categorized into aerospace
and defense, IT and telecom, automotive, medical, industrial, consumer electronics, and others. Among
these, the consumer electronics industry currently exhibits a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global neuromorphic chip market include Applied Brain Research Inc.,
BrainChip Holdings Ltd., General Vision Inc., GrAI Matter Labs, Hewlett Packard Enterprise Development
LP, HRL Laboratories LLC, Intel Corporation, International Business Machines Corporation, Qualcomm
Technologies Inc., Samsung Electronics Co. Ltd., and SK hynix Inc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at